Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy接受免疫治疗的癌症患者抗生素治疗与免疫相关不良事件的关系JOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-01-2054OAAI
FINAL ANALYSIS: PHASE 1B STUDY INVESTIGATING INTRATUMORAL INJECTION OF TOLL-LIKE RECEPTOR 9 AGONIST VIDUTOLIMOD ± PEMBROLIZUMAB IN PATIENTS WITH PD-1 BLOCKADE-REFRACTORY MELANOMAJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-11-106OA